|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2002-3-8
|
|
pubmed:abstractText |
Patients suffering from hepatic metastases of neuroendocrine tumors (NET) are potential candidates for orthotopic liver transplantation. Because recurrence rates are high and outcome is variable, prognostic indicators are required. The aim of our study was to identify predictors of long-term survival with a focus on the impact of tumor biology.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0041-1337
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
73
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
386-94
|
|
pubmed:dateRevised |
2005-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:11884935-Adolescent,
pubmed-meshheading:11884935-Adult,
pubmed-meshheading:11884935-Cadherins,
pubmed-meshheading:11884935-Female,
pubmed-meshheading:11884935-Humans,
pubmed-meshheading:11884935-Immunohistochemistry,
pubmed-meshheading:11884935-Ki-67 Antigen,
pubmed-meshheading:11884935-Liver Neoplasms,
pubmed-meshheading:11884935-Liver Transplantation,
pubmed-meshheading:11884935-Male,
pubmed-meshheading:11884935-Middle Aged,
pubmed-meshheading:11884935-Neuroendocrine Tumors,
pubmed-meshheading:11884935-Prognosis,
pubmed-meshheading:11884935-Tumor Suppressor Protein p53
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors.
|
|
pubmed:affiliation |
Department of Gastroenterology and Hepatology, Medical School of Hannover, 30171 Hannover, Germany.
|
|
pubmed:publicationType |
Journal Article
|
